Interstitial Lung Disease

Conditions and Treatments

The UCSF Interstitial Lung Disease Program evaluates all forms of interstitial lung disease (ILD). The following is a list of some of these conditions:

• Acute Eosinophilic Pneumonia
• Acute Interstitial Pneumonia (AIP or Hamman-Rich Syndrome)
• Asbestosis
• Bronchiolitis
• Chronic Eosinophilic Pneumonia
• Connective Tissue-related ILD
  • Myositis-related ILD
  • Rheumatoid arthritis-related ILD
  • Scleroderma-related ILD
  • Sjogren's syndrome-related ILD
  • Systemic Lupus Erythematosis-related ILD
  • Undifferentiated Connective Tissue Disease-related ILD
• Cryptogenic Organizing Pneumonia (COP)
• Desquamative Interstitial Pneumonia (DIP)
• Diffuse Alveolar Hemorrhage (DAH)
• Drug-related ILD
• Hypersensitivity Pneumonitis
• Idiopathic Pulmonary Fibrosis (IPF)
• Langerhan's Cell Histiocytosis (aka Eosinophilic granuloma or Histiocytosis X)
• Lymphangioleiomyomatosis (LAM)
• Lymphocytic interstitial Pneumonia (LIP)
• Non-specific Interstitial Pneumonia (NSIP)
• Pulmonary Alveolar Proteinosis (PAP)
• Radiation fibrosis
• Respiratory Bronchiolitis-related ILD (RB-ILD)
• Sarcoidosis
• Wegener's granulomatosis and other vasculitidies

Reviewed by health care specialists at UCSF Medical Center.
Last updated September 16, 2008